The following study presented in this article is concerned with a design of novel fusion rules for the low frequency subband coefficients and the high frequency subband coefficients.
For example, Stamps (2008a) finds that an increase of refuge is associated with an increase of feelings of comfort, but his following study presents contrary results (2008b).
The following studies present some similarities with our proposals but differ in how services are handled towards composition or in how the user-interaction is when creating applications through mashups.
The following study presents measurement, design, and analysis issues with which all clinical investigators should be familiar prior to employing patient surveys and questionnaires in their research studies.
The following study presents use of GIS based network analysis to assess the accessibility of UGS at hierarchical levels by applying different network distance to each hierarchy of UGS in a dense and complex urban setting in a developing region.
The following study presents the results of an experimental investigation that compares the bond strength of 24 pull-out and 12 full-scale SCC and CC beams.
The following study presents convincing results concerning efficacy, tolerability and safety of propiverine over placebo in children.
The following study presents the results of density functional theory studies of the properties of a metal molecule assembly resulting from the interaction between an organic molecular linker, dimercaptoacetoamidobenzene and thirteen atom "magic number" gold nanoclusters.
The following studies consecutively presented inconsistent results [ 15, 16, 18, 22].
The following case study presents a patient with a malignant glioma who received standard therapy composed of 6 weeks of radiation with concurrent moderately emetic metronomic oral temozolomide 75 mg/m/day followed by multiple-day adjuvant chemotherapy with oral temozolomide 150 mg/m/day for days 1 5 administered every 28 days for a total of 12 cycles.
74 The following case study presents a patient with testicular cancer who received standard chemotherapy with bleomycin, etoposide, and cisplatin.
